ArticleOphthalmology science2026

The TITAN Study: Topical Infliximab for the Treatment of Advanced Corneal Melt and Ocular Surface Inflammation.

Soumaya Bouhout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.